BiomX Inc. (NYSE AMERICAN: PHGE)
$0.33
-0.0150 ( -4.41% ) 138.8K
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Market Data
Open
$0.33
Previous close
$0.34
Volume
138.8K
Market cap
$22.69M
Day range
$0.31 - $0.36
52 week range
$0.19 - $0.86
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Mar 21, 2024 |
3 | Insider transactions | 1 | Mar 21, 2024 |
8-k/a | 8K-related | 14 | Mar 21, 2024 |
3 | Insider transactions | 3 | Mar 19, 2024 |
4 | Insider transactions | 2 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
8-k | 8K-related | 15 | Mar 18, 2024 |
8-k | 8K-related | 62 | Mar 06, 2024 |
4 | Insider transactions | 1 | Dec 13, 2023 |
4 | Insider transactions | 1 | Dec 13, 2023 |